Aurinia Pharmaceuticals Inc.
AUPH | NASDAQ
$16.70
+$0.09 (+0.54%)
Sep 22, 2026, 11:09 AM ET · Market open
Market Data
Market Cap $2.14B
Enterprise Value $1.75B
Beta 1.41
Average Volume 1.37M
Shares Outstanding (Diluted) 133.53M
Shares Change YoY -6.75%
Institutional Ownership 55.91%
Exchange NASDAQ
ISIN CA05156V1022
Price Performance
Price Change 1M 0.0%
Price Change 3M -7.1%
Price Change 6M 15.6%
Price Change YTD 8.2%
Price Change 1Y 27.1%
Price Change 3Y 98.9%
Price Change 5Y -28.5%
1M CAGR (ann.) 4.8%
1Y CAGR (ann.) 28.9%
5Y CAGR (ann.) -4.5%
All-Time CAGR 12.8%
Valuation
PE Ratio 7.25
Forward PE 13.13
PEG Ratio 0.02
Forward PEG 0.28
PS Ratio 6.86
Forward PS 5.50
PB Ratio 3.47
P/FCF Ratio 10.34
P/Adj. FCF Ratio 10.71
P/OCF Ratio 12.40
EV/Sales 5.63
EV/EBIT 10.39
EV/EBITDA 9.32
EV/FCF 8.49
Earnings Yield 13.8%
FCF Yield 9.7%
Adj. FCF Yield 9.3%
Financial Health
Net Cash $443.12M
Total Debt $60.42M
Cash & Short-Term Investments $443.12M
Total Assets $792.26M
Current Ratio 5.42
Quick Ratio 4.97
Debt / Equity Ratio 0.10
Debt / EBITDA 0.32
Debt / FCF 0.29
OCF / Debt 3.42
Interest Coverage 17.79
Altman Z-Score 7.97
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 90.4%
Operating Profit Margin 48.4%
EBITDA Margin 60.4%
Net Profit Margin 100.8%
FCF Margin 66.3%
Adj. FCF Margin 64.0%
SBC / Revenue 2.5%
SBC Impact (per share) -3.4%
Returns
Return on Assets 39.6%
Return on Equity 59.0%
Return on Invested Capital 21.3%
Return on Capital Employed 21.8%
Return on Tangible Assets 39.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 24.8%
Revenue CAGR 5Y 40.2%
Revenue CAGR 10Y 106.0%
EPS CAGR 3Y 167.8%
EPS CAGR 5Y 558.6%
EPS CAGR 10Y 59.1%
FCF CAGR 3Y 105.2%
FCF CAGR 5Y 357.8%
FCF CAGR 10Y 95.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 15
EPS Growth Next 3Y -11.2%
Revenue Growth Next 3Y 14.8%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $0.21
EPS Growth Est (next Q) -8.7%
Revenue Est (next Q) $83.61M
Revenue Growth Est (next Q) 13.8%
Fair Value Estimates
Graham Number $15.61
Graham Upside -6.0%
Lynch Fair Value $57.25
Lynch Upside 244.7%
Price Target $16
Price Target Upside -3.7%
Cash Flow
Operating Cash Flow $206.71M
Free Cash Flow $206.49M
Adj. Free Cash Flow $199.47M
FCF Per Share $1.33
OCF Per Share $1.34
OCF/S Ratio 55.8%
Income Statement
Revenue $311.51M
Gross Profit $281.47M
Operating Income $150.75M
EBITDA $188.22M
Net Income $314.11M
EPS (Diluted) $2.29
Revenue / Employee $2.43M
Profit / Employee $2.45M
Employees 128
Add to Watchlist
Select watchlists to add or remove AUPH